Surgery

Activities

Activities per year 2015 2017 2021

• 53 Oral presentation
• 30 Invited talk
• 7 Editorial work
• 5 Membership of committee
• 3 More
  • 2 Organising a conference, workshop, ...
  • 1 Examination

Activities per year

Search results

• Het afweersysteem; Werking van vaccins

  Marjolein van Egmond (Speaker)

  14 Jan 2021

  Activity: Talk or presentation › Invited talk

• Augmented anticancer BsAb boost neutrophil cytotoxicity.

  Marjolein van Egmond (Speaker)

  4 Nov 2021

  Activity: Talk or presentation › Invited talk

• Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona

  Marjolein van Egmond (Speaker)

  2 Feb 2021

  Activity: Talk or presentation › Invited talk

• IgA and neutrophil FcαRI: the past, present and future.

  Marjolein van Egmond (Speaker)

  26 Mar 2021

  Activity: Talk or presentation › Invited talk

• e-seminar ‘Covid-19 vaccines'

  Marjolein van Egmond (Speaker)

  7 Jan 2021

  Activity: Talk or presentation › Invited talk

• Augmented anticancer BsAb boost neutrophil cytotoxicity.

  Marjolein van Egmond (Speaker)

  11 Nov 2021

  Activity: Talk or presentation › Invited talk

• Een prik; waarom zou ik

  Marjolein van Egmond (Speaker)

  17 Jan 2021

  Activity: Talk or presentation › Invited talk

• Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity

  Marjolein van Egmond (Speaker)

  5 Oct 2021

  Activity: Talk or presentation › Invited talk

• Openingspitch COVID-19 vaccines

  Marjolein van Egmond (Speaker)

  26 May 2021

  Activity: Talk or presentation › Invited talk

• Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona

  Marjolein van Egmond (Speaker)

  14 Apr 2021

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A: Trojan horse or magic bullet?

  Marjolein van Egmond (Speaker)

  9 Jan 2020

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Speaker)

  2 Feb 2020 → 7 Feb 2020

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Speaker)

  7 Feb 2020

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Speaker)

  24 Aug 2020 → 27 Aug 2020

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Speaker)

  12 Nov 2020

  Activity: Talk or presentation › Invited talk

• Annals of Surgical Oncology (Journal)

  Robert-Jan Coelen (Reviewer)

  2020 → …

  Activity: Publication peer-review and editorial work › Editorial work

• Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Speaker)

  2 Nov 2020 → 4 Nov 2020

  Activity: Talk or presentation › Invited talk

• IgA in autoimmunity and in therapy.

  Marjolein van Egmond (Invited speaker)

  17 Jun 2019

  Activity: Talk or presentation › Invited talk

• Immunoglobulin A: Trojan horse or magic bullet?

  Marjolein van Egmond (Keynote speaker)

  10 Dec 2019

  Activity: Talk or presentation › Invited talk

• ‘Targeting of the IgA Fc receptor in disease’.

  Marjolein van Egmond (Invited speaker)

  26 Jun 2019

  Activity: Talk or presentation › Invited talk

• IgA as anti-cancer therapeutic antibodies 2.0?

  Marjolein van Egmond (Invited speaker)

  21 May 2019

  Activity: Talk or presentation › Invited talk

• AI&II retreat

  Marjolein van Egmond (Participant)

  6 Jun 2019

  Activity: Participating in or organising an event › Organising a conference, workshop, ...

• French National Research Agency (ANR) (External organisation)

  Marjolein van Egmond (Chair)

  1 Jan 2019 → 31 Dec 2019

  Activity: Membership › Membership of committee

• Immunoglobulin A: Trojan horse or magic bullet?

  Marjolein van Egmond (Invited speaker)

  27 Aug 2019

  Activity: Talk or presentation › Invited talk

• British Journal of Surgery (Journal)

  Robert-Jan Coelen (Reviewer)

  2019 → …

  Activity: Publication peer-review and editorial work › Editorial work

• The Lancet Oncology (Journal)

  Robert-Jan Coelen (Reviewer)

  2019 → …

  Activity: Publication peer-review and editorial work › Editorial work

• ‘Immunoglobulin A: Trojan horse or magic bullet?’

  Marjolein van Egmond (Invited speaker)

  11 Sep 2018

  Activity: Talk or presentation › Invited talk

• Keystone Symposium ‘Antibodies as Drugs: Translating Molecules into Treatments’, (Event)

  M van Egmond (Chair)

  2018

  Activity: Membership › Membership of committee

• ‘Translating antibody – effector cell cross-talk to immunotherapy’.

  Marjolein van Egmond (Invited speaker)

  17 Apr 2018 → 18 Apr 2018

  Activity: Talk or presentation › Invited talk

• 5th European Congress of Immunology

  M van Egmond (Organiser)

  2018

  Activity: Participating in or organising an event › Organising a conference, workshop, ...

• thesis committee •J.P. Veluchamy

  M van Egmond (Examiner)

  2018

  Activity: Examination

• Thesis committee E. Heideveld, Sanquin (External organisation)

  Marjolein van Egmond (Chair)

  2018

  Activity: Membership › Membership of committee

• ‘Enlisting myeloid effectors cells in the fight against cancer’.

  M van Egmond (Invited speaker)

  Jan 2018

  Activity: Talk or presentation › Invited talk

• Gordon Research Conference ‘Antibody Biology and Engineering (Event)

  M van Egmond (Chair)

  2018

  Activity: Membership › Membership of committee

• ‘Translating antibody – effector cell cross-talk to immunotherapy’.

  Marjolein van Egmond (Invited speaker)

  25 Feb 2018 → 2 Mar 2018

  Activity: Talk or presentation › Invited talk

• ‘Immunoglobulin A: Trojan horse or magic bullet?’

  Marjolein van Egmond (Invited speaker)

  12 Sep 2018

  Activity: Talk or presentation › Invited talk

• ‘Immunoglobulin A: Trojan horse or magic bullet?’

  M van Egmond (Invited speaker)

  Jun 2018

  Activity: Talk or presentation › Invited talk

• Journal of Vascular and Interventional Radiology (Journal)

  Robert-Jan Coelen (Reviewer)

  2018 → …

  Activity: Publication peer-review and editorial work › Editorial work

• ‘Immunoglobulin A: Trojan horse or magic bullet?’

  Marjolein van Egmond (Invited speaker)

  14 Sep 2018

  Activity: Talk or presentation › Invited talk

• ‘Immunoglobulin A; Trojan horse or magic bullet?’

  Marjolein van Egmond (Keynote speaker)

  21 Apr 2018

  Activity: Talk or presentation › Invited talk

• European Phagocyte Group (External organisation)

  M van Egmond (Member)

  2018

  Activity: Membership › Membership of committee

• ‘Immunoglobulin A: Trojan horse or magic bullet?’

  Marjolein van Egmond (Invited speaker)

  6 Dec 2018

  Activity: Talk or presentation › Invited talk

• Annals of Surgery (Journal)

  Robert-Jan Coelen (Reviewer)

  2017 → …

  Activity: Publication peer-review and editorial work › Editorial work

• In Vitro Studies Show How To Improve The Results Of Ch/EVAR And Ch/EVAS With The Nellix Graft

  JD Blankensteijn (Speaker)

  14 Nov 2017

  Activity: Talk or presentation › Oral presentation

• Microbubbles in thrombolysis; predicting rupture by skin biopsies.

  KK Yeung (Speaker)

  17 Nov 2017

  Activity: Talk or presentation › Oral presentation

• Online Health Information Seeking Behavior in Patients With Upper Extremity Injury.

  S Özkan (Speaker)

  2 Dec 2017

  Activity: Talk or presentation › Oral presentation

• Long-Term Results Of The DREAM RCT Differ From Those Of EVAR 1: EVAR Is Therefore Superior To Open Repair: Why The Difference

  JD Blankensteijn (Speaker)

  14 Nov 2017

  Activity: Talk or presentation › Oral presentation

• Complexe Type B Dissecties.

  AWJ Hoksbergen (Speaker)

  14 Sep 2017

  Activity: Talk or presentation › Oral presentation

• Histology of aortic aneurysms.

  KK Yeung (Speaker)

  19 May 2017

  Activity: Talk or presentation › Oral presentation

• Preventie van littekenbreuken.

  GH van Ramshorst (Speaker)

  2017

  Activity: Talk or presentation › Oral presentation